Recent News for ZLAB - Zai Lab Limited

Date Title
May 21 Zai Lab Announces Early Completion of Enrollment for ZL-2306 PK Study
May 18 Zai Lab (ZLAB) Presents At Bank Of America Merrill Lynch 2018 Healthcare Conference - Slideshow
May 2 Zai Lab reports FY results
May 2 Zai Lab Reports Full Year 2017 Financial Results and Corporate Update
Apr 27 Blog Exposure - Zai Lab Inks Exclusive License Deal with Entasis for ETX2514 in the Asia/Pacific Region
Apr 25 Zai Lab in-licenses Entasis Therapeutics' broad-spectrum antibiotic in Asia-Pacific; shares up 3%
Apr 25 Entasis Therapeutics and Zai Lab Announce Exclusive License Agreement in Asia-Pacific and Global Strategic Development Collaboration for ETX2514
Apr 24 Zai Lab Limited Announces Presentations at May Investor Conferences
Mar 14 Zai Lab: A Short Ahead Of Lockup Expiration
Mar 5 Zai Lab Limited Appoints Billy Cho as Chief Financial Officer
Mar 5 China's Tasly to list biotech arm in $1 bln Hong Kong IPO - sources
Feb 21 Should You Be Concerned About Zai Lab Limited’s (NASDAQ:ZLAB) Shareholders?
Feb 7 Zai Lab Limited to present at the Leerink Partners 7th Annual Global Healthcare Conference
Jan 12 PARP competitors under pressure as AstraZeneca nabs U.S. OK for Lynparza in breast cancer
Jan 3 Zai Lab Limited to present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 19 Five Prime Therapeutics and Zai Lab Announce Exclusive License Agreement for FPA144 Anti-FGFR2b Antibody in Greater China and Global Strategic Development Collaboration
Nov 23 Zai Lab Limited (ZLAB): Is Now The Time To Bet On Healthcare?
Nov 8 Why Zai Lab Limited’s (ZLAB) Investor Composition Impacts Your Returns
Oct 28 Stocks to watch next week
Sep 24 IPO News This Week: Roku, PQ Group Lead 7 Offerings Due Out
Sep 19 Zai Lab Updates Proposed $100 Million U.S. IPO Terms
Aug 24 Zai Lab Files To Raise $115 Million In U.S. IPO
Aug 21 Zai Lab on deck for IPO
Back to the Main ZLAB Page...